Session 219: Advances in RSV: Preparing for Future RSV Vaccines and Immunoprophylaxis Products
The IDWeek 2019 Digital Library is intended as a resource to view IDWeek sessions virtually and claim CME credit. If you plan to claim CME credit for a session, please ensure you have first watched the session video in the DIGITAL LIBRARY prior to completing the evaluation form.
Faculty and Disclosures
Inger Damon, MD, PhD; Director Division of High Consequence Pathogens and Pathology Centers for Disease Control and Prevention, COI Disclosures: Nothing to disclose
Susan Gerber, MD; Chief, Respiratory Viruses Branch, Division of Viral Diseases Centers for Disease Control and Prevention, COI Disclosures: Nothing to disclose
Edward Walsh, MD; Professor of Medicine, University of Rochester, COI Disclosures: "Janssen Pharm: Consultant, no financial payment however Pfizer: Research Grant"
Helen Chu, MD, MPH; Assistant Professor, University of Washington, COI Disclosures: "Merck: Advisory Board Sanofi Pasteur: Research Grant"
Gayle Langley, MD, MPH; Medical epidemiologist, Centers for Disease Control and Prevention, COI Disclosures: Nothing to disclose
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit(s)™